SPAC Litigation Alert: Kwame Amo v. MultiPlan

On March 25, 2021, a shareholder of MultiPlan Corp. f/k/a Churchill Capital Corp III (“New Company”) filed a class action complaint alleging various breach of fiduciary duty claims stemming from a special purpose acquisition company, or “SPAC,” business combination transaction against the New Company, its board of directors (“Board”), and other related parties.

MultiPlan plunges over 20%

MultiPlan (NYSE: MPLN) shares went down over 20% before ending at to $7.01 on Wednesday. This dive comes after Muddy Waters Research releases a short report titled “MultiPlan: Private Equity Necrophilia Meets The Great 2020 Money Grab.”

Churchill Capital Corp III Stockholders Approve Business Combination with MultiPlan

Churchill Capital Corp III (“Churchill III”) (NYSE: CCXX), a public investment vehicle, announced that in a special meeting held today, its stockholders voted to approve its combination with Polaris Parent Corp., the parent of MultiPlan, Inc. (“MultiPlan”), a leading value-added provider of data analytics and technology-enabled end-to-end cost management solutions to the U.S. healthcare industry, and related matters.

The Rise Of SPACs

One of the very interesting topics Directors are hearing about is a liquidity structure called a SPAC (Special Purpose Acquisition Company). As Directors get invited to join Boards of SPACs or do their diligence if a SPAC is right for their private company, I share some information I think will be helpful.